HARTSVILLE, S.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company ("Sonoco" or the "Company") (NYSE: SON), a global leader in high-value sustainable packaging, today announced that it has initiated a review of strategic alternatives for the Company's Thermoformed & Flexible Packaging ("TFP") business, a part of the Company's Consumer Packaging segment. Exploring alternatives for the TFP business is expected to accelerate Sonoco's portfolio simplification strategy, improve pro forma leverage and f ...

Preclinical data has demonstrated the potential of SON-1210, the first albumin-binding bifunctional IL-12/IL-15 fusion protein, for solid tumor immunotherapy An Innovative Immuno Oncology Consortium ("IIOC") led by Oncology experts funded by the Sarcoma Oncology Center will conduct an investigator-initiated Phase 1/2a study of SON-1210 in pancreatic cancer, an indication with significant unmet medical need Company management recently participated in a Virtual Investor KOL Connect segment with world-renowned ...

Sonoco Products Company (NYSE:SON) Q2 2024 Results Conference Call August 1, 2024 9:30 AM ET Company Participants Lisa Weeks - VP of Investor Relations & Corporate Affairs Howard Coker - President, CEO & Director Rob Dillard - Chief Financial Officer Rodger Fuller - Chief Operating Officer Conference Call Participants Matt Roberts - Raymond James George Staphos - BofA Ghansham Panjabi - Baird Mark Weintraub - Seaport Research Partners Gregory Andreopoulos - Citi Operator Good day, and thank you for standing ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-11261 Sonoco Products Company (Exact name of registrant as specified in its charter) South Carolina 57-0248420 (State or other jurisdiction of ...

Sonoco (SON) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.38 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 1.59%. A quarter ago, it was expected that this packaging maker would post earnings of $1.08 per share when it actually produced earnings of $1.12, delivering a surprise of 3.70%. Over the last four quarters, the company has ...

NEWS RELEASE July 31, 2024 Sonoco Reports Second Quarter 2024 Results Hartsville, S.C., U.S. - Sonoco Products Company ("Sonoco" or the "Company") (NYSE: SON), one of the largest sustainable global packaging companies, today reported financial results for its second quarter ended June 30, 2024. Summary: • Achieved GAAP net income attributable to Sonoco of $91 million, Adjusted EBITDA of $262 million, diluted earnings per share of $0.92 and diluted Adjusted earnings per share of $1.28 • Generated strong prod ...

HARTSVILLE, S.C., July 31, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company ("Sonoco" or the "Company") (NYSE: SON), one of the largest sustainable global packaging companies, today reported financial results for its second quarter ended June 30, 2024. Summary: Achieved GAAP net income attributable to Sonoco of $91 million, Adjusted EBITDA of $262 million, diluted earnings per share of $0.92 and diluted Adjusted earnings per share of $1.28 Generated strong productivity of $51 million during the second quart ...

CIPN is a common side effect of many chemotherapeutic drugs that induce peripheral nerve damage. CIPN can last for weeks to years after treatment has ended and patients with CIPN often experience discomfort that can result in persistent, unbearable pain, as well as motor and autonomic dysfunction that may limit the duration of their cancer treatment. Conventional pain medications and opioids are often ineffective against peripheral neuropathy, creating a significant unmet need for new treatment options. Low ...

The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock may move lower. The market expects Sonoco (SON) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare t ...

HARTSVILLE, S.C., July 17, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Sonoco (NYSE: SON) has declared a $0.52 per share quarterly common stock dividend. This dividend will be paid on September 10, 2024, to shareholders of record as of August 9, 2024. About Sonoco According to Howard Coker, President and Chief Executive Officer, this is the 397th consecutive quarter and 99th year, dating back to 1925, that the Company has paid dividends to shareholders, and is the 41st consecutive year the Company ha ...